Laboratory Research Material

GLP3-R 5mg

Research Studies:

  • Multi‑agonist (GLP‑1R/GIPR/GCGR) for receptor signaling assays
  • Supports in vitro study of glucose regulation and insulin pathways
  • Useful for probing energy balance mechanisms across incretin/glucagon signaling
  • Enables assessment of metabolic/cardiometabolic biomarkers in cell models
Batch-Specific COA
U.S. Fulfillment
Research Use Only

Important

Research Use Notice

All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.

Product Documentation

Details, specifications, and reviews

Description

GLP3-R 5mg is a research-use-only laboratory material supplied for controlled research workflows, compound characterization, and analytical documentation review. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.

Key Product Details

  • The listed purity specification is ≥99%; the lot-specific COA documents the tested result for the released lot.
  • Released lots are tested by independent third-party laboratories; review the lot-specific report for the methods performed and results obtained.
  • Supplied in lyophilized powder form to help preserve stability throughout transport and storage.
  • Produced with lot-level traceability to support research documentation and laboratory recordkeeping.

Research Documentation Context

  • Supports compound characterization in controlled laboratory settings.
  • Provides batch-specific identity and purity documentation for research review.
  • Allows lot-level traceability across laboratory documentation workflows.
  • Supports comparison of product labeling, analytical documentation, and storage information during research planning.
  • Supports analytical review of receptor-pathway research materials within a strictly laboratory-focused context.

Specifications and Documentation

  • Certificate of Analysis: Review the lot-specific COA summary in the final product-gallery image and follow its source link or QR code to the original third-party report.
  • Material Safety Data Sheet: Coming Soon.
  • Handling and Storage Instructions: Coming Soon.
  • Product Form: Lyophilized powder.
  • Purity Specification: ≥99% purity.
  • Intended Use: Laboratory research use only.

GLP3-R 5mg Research Planning

The GLP3-R family is cataloged for controlled laboratory study of multi-receptor signaling across GLP-1R, GIPR, and GCGR models. Structural research in this area has combined cryo-electron microscopy with receptor-specific cAMP accumulation experiments to compare how a triple-agonist research model engages each receptor.

Why the 5mg Strength Is a Distinct Product Record

The 5mg vial provides the lowest labeled material amount in the current GLP3-R family. It is suited to procurement plans that need a limited material balance for feasibility work, a focused receptor panel, or initial analytical method setup. Larger planned material requirements can be evaluated against the 10mg, 20mg, and 30mg records. The listed strengths describe total laboratory material only.

Lot Documentation Review

  • Match the 5mg product label to the lot-specific COA summary presented as the final product-gallery image.
  • Record the lot, report number, test date, report date, and sample identifier before material acceptance.
  • Evaluate the reported purity, potency or labeled-content, identity, and mass fields with the stated analytical methods and limitations.
  • Use the summary’s QR code or source link to inspect the original independent third-party laboratory report.

Research reference: Li W, et al. Structural insights into the triple agonism at GLP-1R, GIPR and GCGR manifested by retatrutide. Cell Discovery. 2024;10:77. PMID 39019866.

GLP3-R 5mg is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.

Need Assistance?

Questions about product documentation?

Our support team can assist with product records, lot information, order questions, and certificate verification.

Contact Support